These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 334984)

  • 1. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.
    Greenberg SB; Criswell BS; Six HR; Couch RB
    J Immunol; 1977 Dec; 119(6):2100-6. PubMed ID: 334984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells.
    Kurane I; Binn LN; Bancroft WH; Ennis FA
    J Immunol; 1985 Sep; 135(3):2140-4. PubMed ID: 3926897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
    Nelson DL; Poplack DG; Holiman BJ; Henkart PA
    Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity within the population of NK and K cells.
    Jensen PJ; Koren HS
    J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-influenza human T killer cells present an intertypic activity anti-A and -B type viruses in a secondary reaction in vitro.
    Sitbon M; Gomard E; Hannoun C; Levy JP
    Clin Exp Immunol; 1983 Oct; 54(1):49-58. PubMed ID: 6604611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.
    Yarchoan R; Nelson DL
    J Immunol; 1983 Sep; 131(3):1222-8. PubMed ID: 6309961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
    Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
    J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method.
    Greenberg SB; Criswell BS; Couch RB
    J Immunol; 1975 Aug; 115(2):601-3. PubMed ID: 1151068
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein.
    Ali SA; Rees RC; Oxford J
    Immunology; 1984 Aug; 52(4):687-95. PubMed ID: 6746000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells.
    Klimpel GR; Niesel DW; Klimpel KD
    J Immunol; 1986 Feb; 136(3):1081-6. PubMed ID: 3510252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
    McMichael AJ; Parham P; Brodsky FM; Pilch JR
    J Exp Med; 1980 Aug; 152(2 Pt 2):195s-203s. PubMed ID: 6967937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.
    McMichael AJ; Askonas BA
    Eur J Immunol; 1978 Oct; 8(10):705-11. PubMed ID: 309394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.